 |
市場調査レポート
商品コード
1233333
m-RNA合成サービス市場：用途別、運用規模別、エンドユーザー別（バイオ医薬品企業、CRO、その他）、地域別-規模、シェア、展望、機会分析、2023～2030年m-RNA Synthesis Service Market, By Application, By Scale of Operation, By End User (Biopharmaceutical Companies, Contract research organizations, Others), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| m-RNA合成サービス市場：用途別、運用規模別、エンドユーザー別（バイオ医薬品企業、CRO、その他）、地域別-規模、シェア、展望、機会分析、2023～2030年 |
|
出版日: 2023年02月15日
発行: Coherent Market Insights
ページ情報: 英文 177 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
DNAを鋳型として、メッセンジャーRNA（mRNA）を合成することを転写といいます。mRNAは、核内の染色体DNAから細胞質表面に遺伝情報を運ぶ。mRNAは、遺伝子編集、細胞治療、ワクチン接種、治療用タンパク質の置換などに利用される柔軟なツールです。mRNAを介してあらゆるタンパク質を導入することができるため、遺伝子編集ツールや抗原を細胞内で生産することができます。
mRNAは、遺伝子のDNA鎖の1つに相補的な1本鎖のRNA分子です。合成mRNAは、タンパク質を介したmRNAの認識、mRNAの輸出と翻訳、タンパク質をコードする遺伝子への突然変異の影響などを調べるために使用されます。近年、mRNAを用いた医薬品は、呼吸器疾患、心疾患、代謝性疾患、自己免疫疾患など様々な疾患の治療や、がん、がん免疫療法、予防接種などの目的で開発されています。
市場力学
市場プレイヤー間の買収の増加は、予測期間中の市場成長を促進すると予想されます。例えば、2022年1月、研究者やバイオテクノロジーイノベーターにライフサイエンス試薬とサービスを提供する世界企業であるMaravai LifeSciences, Inc.は、超高純度ヌクレオチドの製造に注力する企業Mychem, LLCを2億4000万米ドルで買収したと発表しています。この買収により、マラバイは、急成長するmRNA治療薬やワクチン用途の市場において、戦略的インプットを提供する製品を拡充します。
製品ポートフォリオを拡大するために、市場の主要企業がm-RNA合成のためのm-RNAベース技術への投資を増やしていることが、予測期間中の市場成長を促進すると予想されます。例えば、2021年12月、金融法人Direxionは、メッセンジャーRNA技術の応用と開発に焦点を当てた新しい上場投資信託（ETF）であるDirexion mRNA ETFの発売を発表しました。本ファンドは、mRNA技術を開発・応用している企業への投資を目的としています。
本調査の主な特徴
- 本レポートは、世界のm-RNA合成サービス市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模（米国）と年間平均成長率（CAGR％）を掲載しています。
- さまざまなセグメントにおける潜在的な収益機会を解明し、この市場に対する魅力的な投資提案マトリクスを解説しています。
- また、市場促進要因、抑制要因、機会、新製品の発売または承認、市場動向、地域展望、主要企業が採用する競争戦略に関する重要な考察を提供します。
- 世界のm-RNA合成サービス市場における主要企業のプロファイルを、企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて掲載しています。本調査の対象となる主要企業には、Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript
- が含まれます。
- 本レポートの洞察により、企業のマーケティング担当者や経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができるでしょう。
- 世界のm-RNA合成サービス市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
- 利害関係者は、世界のm-RNA合成サービス市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査目的と前提条件
- 調査目的
- 前提条件
- 略語について
第2章 マーケットパービュー
- レポート内容
- 市場の定義と範囲
- エグゼクティブサマリー
- 市場スナップショット：アプリケーション別
- 市場スナップショット：運用規模別
- 市場スナップショット：エンドユーザー別
- 市場スナップショット：地域別
- コヒーレント・オポチュニティ・マップ（COM）
第3章 市場力学、規制、動向の分析
- 市場力学
- 促進要因
- 抑制要因
- 市場の魅力度分析
- マーケットオポチュニティ
- 製品発表会
- 合併・買収・共同研究
- 法規制のガイドラインとコンプライアンス
- 主な展開
- PEST分析
- テクノロジー・ランドスケープ
- サービスコスト分析
第4章 m-RNA合成サービスの世界市場-コロナウイルス（COVID-19）のパンデミック別影響
- 経済への影響
- COVID-19疫学
- 需給に与える影響
第5章 m-RNA合成サービスの世界市場：用途別、2017年～2030年
- 治療開発
- ワクチン製造
- 創薬
- その他
第6章 m-RNA合成サービスの世界市場、運用規模別、2017年～2030年
- 研究
- 商業
第7章 m-RNA合成サービスの世界市場、エンドユーザー別、2017年～2030年、（米国百万米ドル
- バイオ製薬会社
- 受託研究機関（CRO）
- その他
第8章 m-RNA合成サービスの世界市場、地域別、2017-2030年
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他ラテンアメリカ地域
- 欧州
- 英国
- ドイツ
- イタリア
- フランス
- スペイン
- ロシア
- その他欧州
- アジア太平洋地域
- 中国
- インド
- 日本
- ASEAN
- オーストラリア
- 韓国
- その他アジア太平洋地域
- 中東
- GCC
- イスラエル
- その他中東地域
- アフリカ
- 北アフリカ
- 中央アフリカ
- 南アフリカ
第9章 競合情勢について
- Maravai LifeSciences
- Azenta US, Inc.
- Creative Biolabs
- Becton, Dickinson And Company
- Creative Biogene
- Kaneka Corporation
- Danaher
- eTheRNA
- Biomay AG
- ApexBio Technology
- RiboPro
- F. Hoffmann-La Roche Ltd
- System Biosciences, LLC.
- Aurigene Pharmaceutical Services Ltd.
- OZ Biosciences
- Aldevron
- GenScript
第10章 セクション
- 調査手法
- 出版社について
目次
Product Code: CMI5537
Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information from the chromosomes' DNA in the nucleus to the surface of the cytosol. mRNA is a flexible tool that is utilized for gene editing, cell therapy, vaccinations, and therapeutic protein replacement, among other . The ability to introduce any protein via mRNA enables the cellular production of gene editing tools or antigens.
mRNA is a single-stranded RNA molecule that is complementary to one of a gene's DNA strands. Synthetic mRNAs are used to investigate protein-mediated mRNA recognition, mRNA export and translation, and mutation effects on protein-coding genes. Recently, mRNA-based medicines have been developed for the treatment of various diseases including respiratory, cardiac, metabolic and autoimmune diseases, as well as cancer, cancer immunotherapy, and preventive vaccinations.
Market Dynamics
Increasing number of acquisitions between market players is expected to drive the market growth over the forecast period. For instance, in January 2022, Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced that it has acquired MyChem, LLC, company focused on making ultra-pure nucleotides, for US$ 240 million. This acquisition will expand Maravai's product offering of strategic inputs in the rapidly growing markets for mRNA therapeutics and vaccine applications.
Increasing investments for m-RNA based technologies for m-RNA synthesis by the key players in the market in order to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2021, Direxion, a financial corporation, announced the launch of the Direxion mRNA ETF, a new exchange-traded fund (ETF) that focuses on the applications and developments of messenger RNA technology. This fund seeks to invest in firms that are developing and applying mRNA technology.
Key features of the study:
- This report provides in-depth analysis of the global m-RNA synthesis service market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global m-RNA synthesis service market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global m-RNA synthesis service market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global m-RNA synthesis service market
Detailed Segmentation:
- Global m-RNA Synthesis Service Market, By Application:
- Therapeutic Development
- Vaccine Production
- Drug Discovery
- Others
- Global m-RNA Synthesis Service Market, By Scale of Operation:
- Research
- Commercial
- Global m-RNA Synthesis Service Market By End User:
- Biopharmaceutical Companies
- Contract research organizations (CROs)
- Others
- Global m-RNA Synthesis Service Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Maravai LifeSciences*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Azenta US, Inc.
- Creative Biolabs
- Becton, Dickinson And Company
- Creative Biogene
- Kaneka Corporation
- Danaher
- eTheRNA
- Biomay AG
- ApexBio Technology
- RiboPro
- F. Hoffmann-La Roche Ltd
- System Biosciences, LLC.
- Aurigene Pharmaceutical Services Ltd.
- OZ Biosciences
- Aldevron
- GenScript
- Maravai LifeSciences*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Scale of Operation
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- Technology Landscape
- Service Cost Analysis
4. Global m-RNA Synthesis Service Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global m-RNA Synthesis Service Market, By Application, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Therapeutic Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Vaccine Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global m-RNA Synthesis Service Market, By Scale of Operation, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Commercial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global m-RNA Synthesis Service Market, By End User, 2017 - 2030, (US$ Million
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global m-RNA Synthesis Service Market, By Region, 2017-2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Maravai LifeSciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Azenta US, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson And Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kaneka Corporation
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher
- Company Highlights
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- eTheRNA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomay AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ApexBio Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RiboPro
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- System Biosciences, LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aurigene Pharmaceutical Services Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OZ Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aldevron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
